Assignee
ANTLERA THERAPEUTICS INC
CA·1 granted patent·6 pending applications·0 citations·filing 2019–2024
Top patents by PatentIndex Score
7 records- 0165US2024228631A9Tetravalent FZD and WNT Co-receptor Binding Antibody Molecules and Uses ThereofANTLERA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0264US2026015424A1Multivalent Binding Molecules Activating WNT Signaling and Uses ThereofANTLERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0359US2023118983A1Tetravalent FZD and WNT Co-receptor Binding Molecules and Uses ThereofANTLERA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0457US2025270332A1Tetravalent FZD and WNT Co-Receptor Binding Antibody Molecules and Uses ThereofANTLERA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0544US2021032352A1Multivalent Binding Molecules Activating WNT Signaling and Uses ThereofANTLERA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0643US12583919B2Antibodies that bind to LRP6 proteins and methods of useANTLERA THERAPEUTICS INC·Filed 2020·Granted Mar 24, 2026·0 cites·16 claims
- 0740US2022315659A1Multivalent FZD and WNT Binding Molecules and Uses ThereofANTLERA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →